Flavopiridol Can Be Safely Administered Using a Pharmacologically Derived Schedule and Demonstrates Activity in Relapsed and Refractory Non-Hodgkin’s Lymphoma

Flavopiridol is a broad cyclin-dependent kinase inhibitor (CDKI) that induces apoptosis of malignant lymphocytes in vitro and in murine lymphoma models. We conducted a phase I dose-escalation study to determine the maximum tolerated dose (MTD) for single-agent flavopiridol administered on a pharmaco...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jones, Jeffrey A., Rupert, Amy S., Poi, Ming, Phelps, Mitch A., Andritsos, Leslie, Baiocchi, Robert, Benson, Don M., Blum, Kristie A., Christian, Beth, Flynn, Joseph, Penza, Sam, Porcu, Pierluigi, Grever, Michael R., Byrd, John C.
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150545/
https://ncbi.nlm.nih.gov/pubmed/23959599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23568
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы